This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Browne, H Articles by Minson, T Search for Related Content PubMed PubMed Citation Articles by Browne, H Articles by Minson, T

 Previous Article  |  Next Article 

J Virol. 1992 November; 66(11): 6784-6787

Construction and characterization of a human cytomegalovirus mutant with the UL18 (class I homolog) gene deleted.

Department of Pathology, University of Cambridge, United Kingdom.

ABSTRACT

The UL18 open reading frame of human cytomegalovirus (HCMV) (which encodes a product homologous to major histocompatibility complex class I heavy chains) has been disrupted by insertion of the beta-galactosidase gene under control of the major HCMV early promoter. The recombinant virus delta UL18 showed no phenotypic differences from wild-type HCMV in terms of single-step growth curves or particle/infectivity ratios, indicating that the UL18 gene product is dispensable for the growth of HCMV in human fibroblasts in vitro. The synthesis of the mature cellular class I heterodimer is shut down in cells infected at a high multiplicity with wild-type HCMV, and a similar effect was seen in delta UL18-infected fibroblasts, suggesting that although the UL18 gene product can associate with beta 2 microglobulin, it is not directly involved in the disruption of class I assembly.

This article has been cited by other articles:

• Occhino, M., Ghiotto, F., Soro, S., Mortarino, M., Bosi, S., Maffei, M., Bruno, S., Nardini, M., Figini, M., Tramontano, A., Ciccone, E. (2008). Dissecting the Structural Determinants of the Interaction between the Human Cytomegalovirus UL18 Protein and the CD85j Immune Receptor. J. Immunol. 180: 957-968 [Abstract] [Full Text]  
• Maffei, M., Ghiotto, F., Occhino, M., Bono, M., De Santanna, A., Battini, L., Gusella, G. L., Fais, F., Bruno, S., Ciccone, E. (2008). Human Cytomegalovirus Regulates Surface Expression of the Viral Protein UL18 by Means of Two Motifs Present in the Cytoplasmic Tail. J. Immunol. 180: 969-979 [Abstract] [Full Text]  
• Wagner, C. S., Ljunggren, H.-G., Achour, A. (2008). Immune Modulation by the Human Cytomegalovirus-Encoded Molecule UL18, a Mystery Yet to Be Solved. J. Immunol. 180: 19-24 [Abstract] [Full Text]  
• Prod'homme, V., Griffin, C., Aicheler, R. J., Wang, E. C. Y., McSharry, B. P., Rickards, C. R., Stanton, R. J., Borysiewicz, L. K., Lopez-Botet, M., Wilkinson, G. W. G., Tomasec, P. (2007). The Human Cytomegalovirus MHC Class I Homolog UL18 Inhibits LIR-1+ but Activates LIR-1- NK Cells. J. Immunol. 178: 4473-4481 [Abstract] [Full Text]  
• Wagner, C. S., Riise, G. C., Bergstrom, T., Karre, K., Carbone, E., Berg, L. (2007). Increased Expression of Leukocyte Ig-Like Receptor-1 and Activating Role of UL18 in the Response to Cytomegalovirus Infection. J. Immunol. 178: 3536-3543 [Abstract] [Full Text]  
• Griffin, C., Wang, E. C. Y., McSharry, B. P., Rickards, C., Browne, H., Wilkinson, G. W. G., Tomasec, P. (2005). Characterization of a highly glycosylated form of the human cytomegalovirus HLA class I homologue gpUL18. J. Gen. Virol. 86: 2999-3008 [Abstract] [Full Text]  
• Saverino, D., Ghiotto, F., Merlo, A., Bruno, S., Battini, L., Occhino, M., Maffei, M., Tenca, C., Pileri, S., Baldi, L., Fabbi, M., Bachi, A., De Santanna, A., Grossi, C. E., Ciccone, E. (2004). Specific Recognition of the Viral Protein UL18 by CD85j/LIR-1/ILT2 on CD8+ T Cells Mediates the Non-MHC-Restricted Lysis of Human Cytomegalovirus-Infected Cells. J. Immunol. 172: 5629-5637 [Abstract] [Full Text]  
• Odeberg, J., Browne, H., Metkar, S., Froelich, C. J., Branden, L., Cosman, D., Soderberg-Naucler, C. (2003). The Human Cytomegalovirus Protein UL16 Mediates Increased Resistance to Natural Killer Cell Cytotoxicity through Resistance to Cytolytic Proteins. J. Virol. 77: 4539-4545 [Abstract] [Full Text]  
• Emery, V C (2001). Investigation of CMV disease in immunocompromised patients. J. Clin. Pathol. 54: 84-88 [Abstract] [Full Text]  
• Beisser, P. S., Kloover, J. S., Grauls, G. E. L. M., Blok, M. J., Bruggeman, C. A., Vink, C. (2000). The r144 Major Histocompatibility Complex Class I-Like Gene of Rat Cytomegalovirus Is Dispensable for both Acute and Long-Term Infection in the Immunocompromised Host. J. Virol. 74: 1045-1050 [Abstract] [Full Text]  
• Leong, C. C., Chapman, T. L., Bjorkman, P. J., Formankova, D., Mocarski, E. S., Phillips, J. H., Lanier, L. L. (1998). Modulation of Natural Killer Cell Cytotoxicity in Human Cytomegalovirus Infection: The Role of Endogenous Class I Major Histocompatibility Complex and a Viral Class I Homolog. J. Exp. Med. 187: 1681-1687 [Abstract] [Full Text]